Quantitative analysis of permeation peptide complexes labeled with technetium-99m: Chiral and sequence-specific effects on net cell uptake

Bioconjugate Chemistry

Volumn 14, Issue 2, 2003, Pages 368-376

  Gammon, Seth T ^a   Villalobos, Victor M ^a   Prior, Julie L ^a   Sharma, Vijay ^a   Piwnica Worms, David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; CELLS; CHIRALITY; CONTROLLED DRUG DELIVERY; CYTOLOGY; TECHNETIUM;

CELL PERMEATION; CELL UPTAKE; CONTROL EXPERIMENTS; LEUKAEMIA CELLS; PEPTIDE COMPLEX; PEPTIDE SEQUENCES; SIDE-CHAINS; SPECIFIC EFFECTS; TECHNETIUM-99M; UPTAKE VALUES;

PEPTIDES;

PEPTIDE LIBRARY; PROTEINASE; TECHNETIUM 99M; TRANSACTIVATOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE PERMEABILITY; CHELATION; CHIRALITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKEMIA CELL LINE; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS;

EID: 0037345697     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0256291     Document Type: Article

References (45)

1. Lebleu, B. (1996) Delivering information-rich drugsprospects and challenges. Trends Biotechnol. 14, 109-110.
2. Frankel, A., and Pabo, C. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
3. Green, M., and Loewenstein, P. (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188.
4. Schwarze, S., Hruska, K., and Dowdy, S. (2000) Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10, 290-295.
5. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., S, T., Ueda, K., and Sugiura, Y. (2001) Arginine-rich Peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840.
6. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
7. Derossi, D., Joliot, A., Chassaing, G., and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450.
8. Lin, Y., Yao, S., Veach, R., Torgenson, T., and Hawiger, J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255-14258.
9. Pooga, M., Hallbrink, M., Zorko, M., and Langel, U. (1998) Cell penetration by transportan. FASEB J. 12, 67-77.
10. Elliot, G., and O'Hare, P. (1997) Intercellular trafficking and protein delivery by a Herpesvirus structural protein, Cell 88, 223-233.
11. Wender, P., Mitchell, D., Pattabiraman, K., Pelkey, E., Steinman, L., and Rothbard, J. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97, 13003-13008.
12. Schwarze, S., Ho, A., Vocero-Akbani, A., and Dowdy, S. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
13. Polyakov, V., Sharma, V., Dahlheimer, J., Pica, C., Luker, G., and Piwnica-Worms, D. (2000) Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjugate Chem. 11, 762-771.
14. 99mTc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjugate Chem. 13, 1226-1237.
15. Kim, D., Mitchell, D., Brockstedt, D., Fong, L., Nolan, G., Fathman, C., Engelman, E., and Rothbard, J. (1997) Introduction of soluble proteins into MHC class I pathways by conjugation to an HIV tat peptide. J. Immunol. 159, 1666-1668.
16. Kip1 induces cell migration. Nat. Med. 4, 1449-1452.
17. Gius, D., Ezhevsky, S., Becker-Hapak, M., Nagahara, H., Wei, M., and Dowdy, S. (1999) Transduced p16INK4a peptides inhibit hypophosphorylation of retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res. 59, 2577-2580.
18. Lewin, M., MCarlesso, N., Tung, C., Tang, X., Cory, D., Scadden, D., and Weissleder, R. (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410-414.
19. Prochiantz, A. (1999) Homeodomain-Derived Peptides: In and Out of the Cells. Ann. N.Y. Acad. Sci. 886, 172-179.
20. Violini, S., Sharma, V., Prior, J., Dyszlewski, M., and Piwnica-Worms, D. (2002) Evidence for a plasma membranemediated permeability barrier to Tat basic domain in welldifferentiated epithelial cells: lack of correlation with heparan sulfate. Biochemistry 41, 12652-12661.
21. Scheller, A., Wiesner, B., Melzig, M., Bienert, M., and Oehlke, J. (2000) Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides. Eur. J. Biochem. 267, 6043-6049.
22. Polyakov, V., Sharma, V., Dahlheimer, J., and PiwnicaWorms, D. (1999) Synthesis and characterization in vitro of membrane permeant peptide conjugates for imaging and radiotherapy. J. Labeled Compd. Radiopharm. 42, S4-S6.
23. Cullis, P., Hope, M., Bally, M., Madden, T., Mayer, L., and Fenske, D. (1997) Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim. Biophys. Acta 1331, 187-211.
24. Isenman, L., Liebow, C., and Rothman, S. (1995) Transport of proteins across membranes - a paradigm in transition. Biochim. Biophys. Acta 1241, 341-370.
25. Nagle, J., and Tristram-Nagle, S. (2000) Structure of lipid bilayers. Biochim. Biophys. Acta 1469, 159-195.
26. Chance, B. (1994) Noninvasive approaches to tissue bioenergetics. Biochem. Soc. Trans. 22, 983-987.
27. 99mTc. J. Am. Chem. Soc. 121, 6076-6077.
28. Peng, C., Graves, P., Thoma, R., Wu, Z., Shaw, A., and Piwnica-Worms, H. (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505.
29. Bosch, I., Crankshaw, C., Piwnica-Worms, D., and Croop, J. (1997) Characterization of functional assays of P-glycoprotein transport activity. Leukemia 11, 1131-1137.
30. -: carrier free? J. Nucl. Med. 16, 639-641.
31. Piwnica-Worms, D., Kronauge, J., and Chiu, M. (1990) Uptake and retention of hexakis (2-methoxy isobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 82, 1826-1838.
32. Glantz, S. A. (1987) Primer of Biostatistics, 2nd ed., p 379, Mcgraw-Hill, Inc., New York.
33. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G., and Dowdy, S. (2001) Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477.
34. Subramanian, T., Govindarajan, R., and Chinnadurai, G. (1991) Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation. EMBO J. 10, 2311-2318.
35. Lindgren, M., Hallbrink, M., Prochiantz, A., and Langel, U. (2000) Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99-103.
36. Waibel, R., Alberto, R., Willuda, J., Finnern, R., Schibli, R., Stichelberger, A., Egli, A., Abram, U., Mach, J.-P., Pluckthun, A. et al. (1999) Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat. Biotechnol. 17, 897-901.
37. Buschle, M., Schmidt, W., Auner, W., Mechtler, K., Trska, B., Kirlappos, H., and Birnstiel, M. (1997) Transloading of tumor antigen-derived peptides into antigen-presenting cells. Proc. Natl. Acad. Sci. U.S.A. 94, 3256-3261.
38. Tyagi, M., Rusnati, M., Presta, M., and Giacca, M. (2001) Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261.
39. Silhol, M., Tyagy, M., Giacca, M., Lebleu, B., and Vives, E. (2002) Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. 269, 494-501.
40. Vocero-Akbani, A., Lissy, N., and Dowdy, S. (2000) Transduction of Full-Length Tat Fusion Proteins Directly into Mammalian Cells: Analysis of T Cell Receptor ActivationInduced Cell Death. Methods Enzymol. 322, 508-521.
41. Mujeeb, A., Bishop, K., Peterline, M. B., Christoph, T., Parslow, T. G., and James, T. L. (1994) NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat. Proc. Natl. Acad. Sciences U.S.A. 91, 8248-8252.
42. Metzger, A. U., Schindler, T., Willbold, D., Kraft, M., Steegborn, C., Volkmann, A., Frank, R. W., and Rosch, P. (1996) Structural rearrangements on HIV-1 Tat (32-72) TAR complex formation. FEBS Lett. 384, 255-259.
43. Rould, M., Perona, J., Soll, D., and Steitz, T. (1989) Science 246, 1135-1142.
44. Ye, X., Gorin, A., Ellington, A. D., and Patel, D. J. (1996) Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex. Nat. Struct. Biol. 3, 1026-1033.
45. Jurisson, S., and Lydon, J. (1999) Potential technetium small molecule radipharmaceuticals. Chem. Rev. 99, 2205-2218.